Oct. 1, 2026 DRG reimbursement could speed hospital adoption; $80.3M in liquidity may support breakeven without a raise.

The bull case for (CRGY): acquisitions bolster fundamentals, and debt reduction could rerate its low-P/E shares as it targets ...

The financial markets experienced heightened volatility in the third quarter in response to a rapidly changing macroeconomic ...

The bull case on OMSE: it trades just above net cash with growth and positive earnings, and its valuation could improve as ...

The rates market this week raised expectations for the December policy rate by 16 bps to 4.16% - implying 100% probability ...

Analyst rates Mercury General a Buy: a 90.2% Q3 combined ratio and low operating earnings multiple support the thesis; ...

Analyst rates (FSLR) a Hold at $193.84 with 8.8% upside, below the required return; core operations are unprofitable without ...

Analyst rates CubeSmart (CUBE) a Buy, citing its 4.7% dividend yield and 1.25x coverage; elevated leverage and mixed ...

Analyst sees MUC CEF as tax-free income for patient, high-bracket investors at a 6.42% yield; its 10.7% NAV discount is not a ...

Bart Melek, Head of Commodities at TD Securities, discusses the pressures on copper and oil prices and why tight crude ...

Anthony Imbesi, Vice President & Director, High Yield Portfolio Management, TD Asset Management, explains why careful ...

Q3 marketplace volume rose 135% to $5.80 billion, and higher 2027 forecasts and valuation support substantial upside.